Prosecution Insights
Last updated: August 17, 2026

Examiner: STEELE, AMBER D

Tech Center 1600 • Art Units: 1627 1639 1645 1654 1658 1676

This examiner grants 59% of resolved cases

Performance Statistics

59.0%
Allow Rate
-1.0% vs TC avg
879
Total Applications
+9.7%
Interview Lift
1252
Avg Prosecution Days
Based on 818 resolved cases, 2023–2026

Rejection Statute Breakdown

8.1%
§101 Eligibility
20.2%
§102 Novelty
25.7%
§103 Obviousness
25.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17768537 Bi-Peptide with Affinity to Extracellular Matrix Proteins or Cells and to Growth Factors for Tissue Healing and Regeneration Final Rejection Mayo Foundation for Medical Education and Research
17433009 CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY Non-Final OA The Regents of the University of Michigan
19351688 PROCESSES AND INTERMEDIATES FOR PREPARING TIRZEPATIDE Final Rejection ELI LILLY AND COMPANY
18037098 VIBRIO TOXIN BINDING PROTEINS IN SHRIMP AND USES THEREOF Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
18172116 COMPOSITIONS AND METHODS FOR TREATING DISEASES Non-Final OA Sanford Burnham Prebys Medical Discovery Institute

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month